Last update 20 Mar 2025

Polyadenylic polyuridylic acid

Overview

Basic Info

Drug Type
Oligonucleotide
Synonyms
PolyA PolyU, Polyadenur
+ [1]
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal DiseasesInfectious Diseases+ [3]
Active Indication-
Inactive Indication
Breast CancerHepatitis BHIV Infections+ [1]
Originator Organization
AIM ImmunoTech, Inc.AIM ImmunoTech, Inc.
Active Organization-
Inactive Organization
Ipsen SAIpsen SAAIM ImmunoTech, Inc.AIM ImmunoTech, Inc.
Drug Highest PhasePendingNDA/BLA
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC19H27N7O16P2
InChIKeyVGQHQOKIMNKUEF-ZLOOHWKQSA-N
CAS Registry24936-38-7
Boost your research with our RNA technology data.
login
or
view full example data
Boost your research with our RNA technology data.

Related

100 Clinical Results associated with Polyadenylic polyuridylic acid
Login to view more data
100 Translational Medicine associated with Polyadenylic polyuridylic acid
Login to view more data
100 Patents (Medical) associated with Polyadenylic polyuridylic acid
Login to view more data
3
Literatures (Medical) associated with Polyadenylic polyuridylic acid
08 Aug 1970Biochimica et biophysica acta
[Effect of monovalent cations on the dissociation of rat liver ribosomes. Properties of the subunits].
01 Mar 1970Journal of the Reticuloendothelial Society
Synthetic polynucleotides as restorers of normal antibody-forming capacities in aged mice.
01 Dec 1966Acta embryologiae et morphologiae experimentalis
The effects of homopolyribonucleotides on the development of ascidian eggs.
100 Deals associated with Polyadenylic polyuridylic acid
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Breast CancerNDA/BLA-
AIM ImmunoTech, Inc.AIM ImmunoTech, Inc.
-
Breast CancerNDA/BLA
France
Ipsen SAIpsen SA
-
Hepatitis BNDA/BLA
South Korea
Ipsen SAIpsen SA
-
HIV InfectionsNDA/BLA
France
Ipsen SAIpsen SA
-
Stomach CancerNDA/BLA
South Korea
Ipsen SAIpsen SA
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
ASCO2006
Not Applicable
Node-positive breast cancer
Adjuvant
336
(hurrsrkndn) = oazdesmtsp fhswgjpjnp (covnxdcdgf, 45% - 91%)
View more
Positive
20 Jun 2006
(No treatment)
(hurrsrkndn) = ltfcbwynon fhswgjpjnp (covnxdcdgf, 8% - 47%)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free